Literature DB >> 8727524

Alveolar epithelial clearance of protein.

H G Folkesson1, M A Matthay, B R Weström, K J Kim, B W Karlsson, R H Hastings.   

Abstract

Substantial progress has been made in understanding the rate, the pathways, and the mechanisms regulating alveolar protein removal from the uninjured lung. Whole animal studies and cellular studies have demonstrated that the majority of alveolar epithelial protein clearance occurs by passive nondegradative diffusional pathways. Some evidence, however, has been recently presented that alveolar epithelial cells express an albumin-binding receptor as well as a polymeric immunoglobulin receptor, both of which might be important for alveolar epithelial clearance of protein. However, the contribution of these receptors requires further studies. Little is known about alveolar clearance of protein during pathological conditions; further studies are required to determine the roles of the different cell types in the lung for removal of protein from the alveolar spaces of the lung. Alveolar macrophages are likely to play an important role in the degradation and removal of insoluble protein from the distal air spaces after acute lung injury. In conclusion, the present data suggest that most proteins and peptides deposited on the epithelial surfaces in the distal air spaces are cleared as intact molecules, predominantly via paracellular routes. The contribution of pinocytic processes appear to be of minor importance for translocation of bulk quantities of proteins or peptides across the alveolar epithelium.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8727524     DOI: 10.1152/jappl.1996.80.5.1431

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  14 in total

1.  Evidence for the role of alveolar epithelial gp60 in active transalveolar albumin transport in the rat lung.

Authors:  T A John; S M Vogel; R D Minshall; K Ridge; C Tiruppathi; A B Malik
Journal:  J Physiol       Date:  2001-06-01       Impact factor: 5.182

Review 2.  Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications.

Authors:  N R Labiris; M B Dolovich
Journal:  Br J Clin Pharmacol       Date:  2003-12       Impact factor: 4.335

3.  TGF-β inhibits alveolar protein transport by promoting shedding, regulated intramembrane proteolysis, and transcriptional downregulation of megalin.

Authors:  Luciana C Mazzocchi; Christine U Vohwinkel; Konstantin Mayer; Susanne Herold; Rory E Morty; Werner Seeger; István Vadász
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-07-13       Impact factor: 5.464

Review 4.  Pharmacometric Models for Characterizing the Pharmacokinetics of Orally Inhaled Drugs.

Authors:  Jens Markus Borghardt; Benjamin Weber; Alexander Staab; Charlotte Kloft
Journal:  AAPS J       Date:  2015-04-07       Impact factor: 4.009

5.  Technosphere insulin: defining the role of Technosphere particles at the cellular level.

Authors:  Robert Angelo; Kathleen Rousseau; Marshall Grant; Andrea Leone-Bay; Peter Richardson
Journal:  J Diabetes Sci Technol       Date:  2009-05-01

6.  Megalin mediates transepithelial albumin clearance from the alveolar space of intact rabbit lungs.

Authors:  Yasmin Buchäckert; Sebastian Rummel; Christine U Vohwinkel; Nieves M Gabrielli; Benno A Grzesik; Konstantin Mayer; Susanne Herold; Rory E Morty; Werner Seeger; István Vadász
Journal:  J Physiol       Date:  2012-07-23       Impact factor: 5.182

Review 7.  Pharmacokinetics of inhaled nanotherapeutics for pulmonary delivery.

Authors:  Andrew M Shen; Tamara Minko
Journal:  J Control Release       Date:  2020-07-16       Impact factor: 9.776

8.  Riboflavin-enhanced transport of serum albumin across the distal pulmonary epithelium.

Authors:  O D Wangensteen; M M Bartlett; J K James; Z F Yang; P S Low
Journal:  Pharm Res       Date:  1996-12       Impact factor: 4.200

9.  Safety of prolonged, repeated administration of a pulmonary formulation of tissue plasminogen activator in mice.

Authors:  Nicholas P Lackowski; Josh E Pitzer; Meghan Tobias; Zachary Van Rheen; Rajiv Nayar; Mitra Mosharaff; Kathleen A Stringer
Journal:  Pulm Pharmacol Ther       Date:  2009-10-29       Impact factor: 3.410

10.  Matrix metalloproteinase-8 inactivates macrophage inflammatory protein-1 alpha to reduce acute lung inflammation and injury in mice.

Authors:  Pablo A Quintero; Martin D Knolle; Luisa F Cala; Yuehong Zhuang; Caroline A Owen
Journal:  J Immunol       Date:  2009-12-30       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.